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Although phosphatidylinositol 4,5-bisphosphate (PIP2) regulates syndecan-4 function, the potential
inﬂuence of syndecan-4 on PIP2 remains unknown. GFP containing PIP2-binding-PH domain of
phospholipase Cd (GFP-PHd) was used to monitor PIP2. Syndecan-4 overexpression in COS-7 cells
enhanced membrane translocation of GFP-PHd, while the opposite was observed when syndecan-
4 was knocked-down. PIP2 levels were higher in total phospholipids extracted from rat embryo
ﬁbroblasts expressing syndecan-4. Syndecan-4-induced membrane targeting of GFP-PHd was fur-
ther enhanced by phosphoinositide-3-kinase inhibitor, but not by phospholipase C (PLC) inhibitor.
Besides, both ionomycin and epidermal growth factor caused dissociation of GFP-PHd from plasma
membrane, an effect that was signiﬁcantly delayed by syndecan-4 over-expression. Collectively,
these data suggest that syndecan-4 promotes plasma membrane retention of PIP2 by negatively reg-
ulating PLC-dependent PIP2 degradation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Phosphatidylinositol 4,5-bisphosphate (PIP2) is a membrane
phospholipid found in all eukaryotic cells. Hydrolysis of PIP2 by
phospholipase C (PLC) gives rise to two important second messen-
gers: inositol 1,4,5-triphosphate (IP3), which mobilizes Ca2+ from
intracellular stores and DAG, which is a physiological activator of
PKC [1,2]. PIP2 is also a substrate for phosphoinositide 3-kinase
(PI3K), which catalyzes the production of another important second
messenger phosphatidylinositol-3,4,5-trisphosphate [3–5]. In addi-
tion to functioning as a substrate for PLC and PI3K, PIP2 is bona ﬁde
signaling and scaffoldingmolecule, playing a pivotal role in a variety
of cellular processes, including secretory vesicle-plasmamembrane
fusion, clathrin-mediated endocytosis, and endocytic membrane
recoveryduring neurotransmitter release [6–8]. PIP2 is also involved
in regulating actin cytoskeleton organization through its effects on
the activities of actin-binding proteins [9]. For example, PIP2 accu-
mulation in membrane rafts and/or focal adhesions promotes the
recruitment and activation of speciﬁc cellmembrane signaling com-
ponents, thereby providing a link between the plasma membrane
and the actin cytoskeleton [10]. Given the centrality of the actin
cytoskeleton in determining important aspects of cell behaviorchemical Societies. Published by Eand the dependence of certain cytoskeletal functions on PIP2, it is
important for the cell to maintain a steady-state level and spatial
organization of PIP2 in the plasma membrane [11,12]. PIP2 is one
of the major phosphoinositides found in the plasma membrane,
where it represents 1% of total plasma membrane phospholipids
and is present at an effective concentration of 10 lM [13].
Several reports have suggested that distinct pools of PIP2 exist
within the cell and that signiﬁcant amounts of PIP2 become seques-
tered in lateral membrane domains through interaction with
proteins [11]. For example,myristoylatedalanine-richC-kinase sub-
strate (MARCKS) is known to interact with PIP2, and peptides in the
effector domain of MARCKS inhibit PLC-catalyzed PIP2 hydrolysis
[12,14]. The implication is that MARCKS-bound PIP2 is protected
from degradation, suggesting that MARCKS may act as a source of
PIP2 in the plasma membrane. Thus, the diverse functions of PIP2
may ultimately rely on interactions with a large number of PIP2-
modulating molecules, which act by regulating PIP2 availability.
Syndecan-4, a member of the syndecan family, plays a critical
role in focal adhesion and stress ﬁber formation [15]. Syndecan-4
interacts through a motif in the central portion of its cytoplasmic
domain with PIP2 [16,17]. This interaction of PIP2 with syndecan-
4 regulates oligomerization of syndecan-4 cytoplasmic domain,
and also regulates syndecan-4-mediated protein kinase C (PKC)
activation. Both actions are central for syndecan-4-dependent focal
adhesion and stress ﬁber formations [16,18,19]. Although PIP2lsevier B.V. All rights reserved.
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studies have not addressed the possible effects of syndecan-4 on
PIP2 function, or the nature of the interplay between syndecan-4
and PIP2. Here we show that syndecan-4 promotes the retention
of PIP2 in the plasma membrane by inhibiting the metabolic degra-
dation of PIP2 by PLC.2. Materials and methods
2.1. Materials and antibodies
Ionomycin was obtained from A.G. Scientiﬁc Inc. (San Diego,
CA); 1-[6-((17b-3-methoxyestra-1,3,5(10)-trien-17-yl)-amino)-
hexyl]-1H-pyrrole-2,5-dione (U73122), and L-a-phosphatidylcho-
line (PC) were from Calbiochem Inc. (San Diego, CA); and
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
was from BIOMOL Research Laboratories Inc. (Plymouth Meeting,
PA). Monoclonal anti-green ﬂuorescent protein (GFP) antibody
was purchased from BD Biosciences Clontech (Palo Alto, CA).
Polyclonal anti-a-actinin antibody, PIP2 and other chemicals were
purchased from Sigma (St. Louis, MO).
2.2. Cell culture and transfection
COS-7 cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Gibco BRL) supplemented with 10% fetal bovine
serum (FBS), penicillin (100 unit/ml) and streptomycin (10 lg/ml,
Gibco BRL) at 37 C in 5% CO2. COS-7 cells (8  105), plated onto
60-mm-diameter culture dishes, were co-transfected with syndec-
an-4 cDNA (sdc4) or syndecan-2 cDNA (sdc2) and constructs
encoding fusion proteins of PLCd pleckstrin homology (PH)
domains and GFP (a generous gift from Dr. Pann-Ghill Suh of the
Pohang University of Science and Technology of Korea) using the
Polyfect reagent (Qiagen, Valencia, CA). Transfected cells were
maintained in medium containing G418 (2 lg/ml). Rat embryo
ﬁbroblasts (REFs) were cultured in Minimum Essential Medium
(MEM) Alpha (a-MEM, Gibco BRL) supplemented with 5% FBS, pen-
icillin and streptomycin.
2.3. Synthesis of siRNA constructs
siRNA oligonucleotides targeted to monkey syndecan-4 se-
quence (50-CAGCAATATCTTTGAGAGA-30) and scrambled siRNA
(siGENOME Non-targeting siRNA #2) were purchased from Dharm-
acon Inc. (Chicago, IL). COS-7 cells were co-transfected with GFP-
PHd and either control siRNA (si-con) or siRNA oligonucleotides
(si-sdc4) using Lipofectamine 2000 (Invitrogen), according to the
manufacturer’s protocols.
2.4. RNA extraction and reverse transcription polymerase chain
reaction (RT-PCR)
Total RNA extracted from transfected cells was used as template
for reverse transcriptase reaction. Aliquots of cDNA were ampli-
ﬁed using the following primers: syndecan-4 (forward) 50-
CCTCAGTTGCACTAACCACG-30 and (backward) 50-AGCTGAGGCTGT-
GACTCGTT-30. After an initial denaturation at 94 C for 5 min, 30
cycles of denaturation at 94 C for 30 s, annealing at 55 C for 30 s,
and extension at 72 C for 60 s were carried out. The reaction prod-
ucts were analyzed in 1.5% agarose gels.
2.5. Fluorescence microscopy
Cells were seeded onto glass coverslips at a density of 4 
104 cells or into 35 mm culture plates at a density of 1.5  105 cells.After incubation for 48 h, cells were washed twice with PBS, ﬁxed
with 3.5% paraformaldehyde in PBS at room temperature for
10 min, and mounted with VECTASHIELD Mounting Medium (VEC-
TOR Laboratories, Burlingame, CA). Images were obtained by digital
imaging ﬂuorescence microscopy using a CCD camera (Carl Zeiss,
Gottingen, Germany).
2.6. Subcellular fractionation and immunoblotting
Subcellular fractionation and immunoblotting were performed
as described [20].
2.7. Phospholipids separation
Phospholipids were extracted and separated as previously de-
scribed [21]. Brieﬂy, cells were trypsinized and suspended in a
Krebs-Ringer-HEPES buffer (25 mM HEPES [pH 7.2], 115 mM NaCl,
2 mM CaCl2, 1 mM KH2PO4, 1.2 mM MgSO4) at a density of 3 
106 cells/ml, and radiolabeled with 6 lCi of [32P]PO43 per 106 cells
for 120 min at 37 oC. Total cellular lipids were fractionated by
repeated extraction with CHCl3–CH3–2.4N HCl 1.5:1.0:1.5. Lipid
standards (50 lg of PIP2 and 75 lg of PC) or lipid extracts in chloro-
form were spotted on different lanes 1.5 cm from the bottom of the
plate and developed by ascending chromatography in two succes-
sive solvent systems. The ﬁrst acidic solvent system was composed
of CHCl3–CH3OH–CH3COOH–H2O (55:43:3:4). The development
was stopped when the solvent front reached 0.5 cm from the top
of the plate. The plates were allowed to air dry before the second
development in a basic solvent composed of CHCl3–CH3OH–
NH4OH–H2O (40:70:10:20). When the solvent front reached a point
25% of the distance traveled by the ﬁrst solvent, the second develop-
ment was stopped. The plate was allowed to air dry and the lipids
were visualized by autoradiography.
2.8. Statistics analysis
All P values were determined using a two-tailed Students t-test.
Results were considered signiﬁcant at the P < 0.05 level.3. Results
The PH domain of PLCd (PHd) binds PIP2 with high afﬁnity
[22,23]. When expressed as a fusion with green ﬂuorescent protein
(GFP), the resulting GFP-PHd chimera can be used to monitor PIP2
intracellular localization. We expressed GFP-PHd in COS-7 cells
and examined the membrane targeting of GFP-PHd by ﬂuorescence
microscopy using GFP ﬂuorescence intensity as an indicator of PIP2
levels in the plasmamembrane. Cells showing intense ﬂuorescence
at the plasma membrane were counted (Fig. 1A). Consistent with
previous reports [22,23], GFP-PHd was predominantly localized at
the plasmamembrane (37%), but GFP constructs containing other
PLC-PH domains, including PH domains of PLCb (GFP-PHb) and
PLCc (GFP-PHc), were not (<10%). Signiﬁcantly, in cells co-transfec-
ted with syndecan-4, the level of GFP-PHd targeted to the plasma
membrane was 1.5-fold higher than in cells expressing GFP-PHd
alone (Fig. 1A). Similar results were obtained in immunoblotting
experiments using an antibody against GFP, conﬁrming that GFP-
PHd levels were increased in the membrane fraction of syndecan-
4-transfected cells (Fig. 1B). Consistently, knockdown of syndec-
an-4 expression by siRNA reduced the localization of GFP-PHd to
the plasma membrane (Fig. 1C and D). The amount of PIP2 was also
substantially increased in phospholipids separated from REFs sta-
bly overexpressing syndecan-4 compared with vector transfected
cells (Fig. 1E). These results suggest that syndecan-4may positively
regulate plasma membrane retention of endogenous PIP2.
Fig. 1. PIP2 levels are increased in cells overexpressing syndecan-4. (A) COS-7 cells were transfected with syndecan-4 (sdc4) and/or the indicated GFP-PH domain constructs.
Membrane localizations of GFP-PH proteins were examined using ﬂuorescence microscopy. Cells expressing GFP-positive cells featuring GFP-PH domain at the membrane
(inset) were counted. Shown are mean percentages of GFP-positive cells per ﬁeld ± the standard errors of the means. A total of approximately 90 cells were counted for each
bar. *P < 0.01 versus control. (B) COS-7 cells (80% conﬂuent) transfected with GFP-PH (PHd) and/or syndecan-4 cDNA (sdc4) were lysed and fractionated. Lysates containing
20 lg of protein from each membrane fraction were resolved by SDS–PAGE and subjected to immunoblotting with an antibody against GFP (a-GFP). a-Actinin was used as a
loading control. Representative results of at least three independent experiments are shown. (C) COS-7 cells were co-transfected with GFP-PHd cDNAs and either control (si-
con) or syndecan-4 siRNA (si-sdc4). Total RNA was extracted, and expression of syndecan-4 was analyzed by reverse transcription-PCR. b-Actin mRNA was used as the loading
control (top left panel). Membrane localizations of GFP-PH proteins were examined using ﬂuorescence microscopy (top right panel). The average number of membrane GFP-
positive cells featuring GFP-PH domain at the membrane is shown, expressed as a percentage of total cell number (bottom panel). A total of approximately 90 cells were
counted for each bar. *P < 0.01 versus control. (D) COS-7 cells were co-transfected with GFP-PHd and either control siRNA (si-con) or siRNA oligonucleotides (si-sdc4). Both
mRNA expression of syndecan-4 (top panel) and membrane localization of GFP-PHd (bottom panel) were analyzed as described in (B). (E) Phospholipids from exponentially
growing REFs and REFs stably overexpressing syndecan-4 (sdc4) were fractionated by thin-layer chromatography as described in Materials and Methods. The positions of PC
and PIP2 are indicated. The data shown are representative of at least three independent experiments.
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an-4-transfected cells may result from either increased synthesis
or decreased metabolic degradation of PIP2. Because syndecan-4
speciﬁcally interacts with PIP2 [16,17,24], it is more likely that
syndecan-4 regulates the metabolic degradation, rather than syn-
thesis of PIP2. To investigate the effects of syndecan-4 on the met-
abolic degradation of PIP2, we added PIP2 exogenously in the
culture media and, after allowing it to incorporate into the plasma
membrane, monitored GFP-PHdmembrane targeting using ﬂuores-
cence microscopy. As shown in Fig. 2A, exogenously added PIP2
speciﬁcally increased the membrane targeting of GFP-PHd; there
was no change in GFP-PHb or GFP-PHc localization. The increase
in plasma membrane GFP-PHd was transient and reached a
maximum 30 min after PIP2 addition. Western analysis using an
antibody against GFP conﬁrmed that exogenously added PIP2
increased the amounts of GFP-PHd in the membrane fraction
(Fig. 2B). In cells co-transfected with syndecan-4 and GFP-PHd,
membrane targeting of GFP-PHd was increased by 1.5-fold com-
pared with cells transfected with GFP-PHd alone. In addition, the
increased membrane targeting of GFP-PHd in syndecan-4 co-trans-
fected COS-7 cells was further enhanced by exogenous addition of
PIP2 (Fig. 2C). In control experiments using cells transfected with
syndecan-2, the closest homologue of syndecan-4, the membrane
targeting of GFP-PHd was not signiﬁcantly changed. In contrast,
the membrane targeting of GFP-PHd was much higher in syndec-
an-4-transfected cells, and continued to increase beyond 15 min.
At 60 min, membrane-targeted GFP-PHd was detected in 80% of
transfected cells. However, there was no change in GFP-PHb mem-
brane localization (Fig. 2D). These results indicate that syndecan-4
helps to retain PIP2 in the plasma membrane, possibly by regulat-
ing the metabolic degradation of PIP2 in the plasma membrane.
We next investigated the involvement of syndecan-4 in the reg-
ulation of two major downstream pathways, PLC and PI3K, where
PIP2 serves as substrate. In syndecan-4-transfected cells, the pres-ence of the PI3K inhibitor, LY294002, further increased GFP-PHd
membrane targeting and substantially delayed PIP2 degradation
(Fig. 3A). In contrast, the PLC inhibitor, U73122, did not increase
GFP-PHd membrane targeting in syndecan-4-transfected cells
(Fig. 3B). These results suggest that PLC is inhibited in these cells
and implicate syndecan-4 as a negative regulator of PLC-mediated
PIP2 hydrolysis. Interestingly, activation of PLC with 10 lg/ml ion-
omycin caused a rapid dissociation of GFP-PHd from the plasma
membrane that coincided with phosphoinositide breakdown. This
effect of ionomycin was absent, however, in syndecan-4-over-
expressing cells, where GFP-PHd membrane targeting remained
unchanged up to 15 min, implying that syndecan-4 delayed degra-
dation of PIP2 (Fig. 3C). Therefore, it is likely that syndecan-4 neg-
atively regulates PLC-mediated metabolic degradation of PIP2.
Finally, given the prominence of growth factor-mediated cell
signaling pathway, we investigated syndecan-4 involvement in
epidermal growth factor (EGF)-mediated PIP2 metabolism [25].
As expected, EGF (50 ng/ml) increased GFP-PHd membrane target-
ing in mock-transfected cells (vec). EGF-mediated membrane tar-
geting of GFP-PHd was further increased in syndecan-4
overexpressing cells at 30 min (Fig. 4A). Consistently, knockdown
of syndecan-4 expression by siRNA reduced EGF-mediated mem-
brane targeting of GFP-PHd (Fig. 4B). During EGF stimulation in
syndecan-4-transfected cells, the degradation of exogenously
added PIP2 was also delayed (Fig. 4C). When added alone the
PI3K inhibitor, LY294002, in the absence of EGF, increased the
amount of PIP2 in the plasma membrane by 7–15%. In the presence
of LY294002, EGF-induced a transient increase in membrane-tar-
geted GFP-PHd at 30 min in COS-7 cells transfected with empty
vector (vec). However, the membrane targeting of GFP-PHd was
continuously increased up to 90 min in syndecan-4-transfected
COS-7 cells (sdc4). In contrast, the presence of the PLC inhibitor,
U73122, did not enhance EGF-induced GFP-PHd membrane target-
ing in syndecan-4-transfected cells (Fig. 4D). Since PI3K inhibition
Fig. 2. Overexpression of syndecan-4 increases the membrane-residence time of exogenously added PIP2. (A) COS-7 cells transfected with the indicated GFP-PH domain
constructs were treated with 25 lM PIP2. Membrane localization of GFP-PH proteins were examined using ﬂuorescence microscopy. Cells expressing GFP in the plasma
membrane were counted. The average number of membrane GFP-positive cells featuring GFP-PH domain at the membrane is shown, expressed as a percentage of total cell
number. A total of approximately 90 cells were counted for each bar. (B) COS-7 cells (80% conﬂuent) were lysed and fractionated. Lysates containing 20 lg of protein from
each membrane fraction were resolved by SDS-PAGE and subjected to immunoblotting with a-GFP, using a-actinin as a loading control. (C) COS-7 cells co-transfected with
GFP-PHd cDNA and either vector (vec) or syndecan-4 (sdc4) cDNAs were treated with 25 lM PIP2 (+PIP2) for 30 min. Cells expressing GFP in the plasma membrane were
counted. (D) COS-7 cells were co-transfected with cDNAs for GFP-PLC-PH and syndecan-4 (sdc4) or syndecan-2 (sdc2) as indicated. After addition of 25 lM PIP2, mRNA
expression of both syndecan-2 and -4 were analyzed (left panel) and the percent of cells positive for GFP membrane localization at the indicated time periods was quantiﬁed
(right panel). *P < 0.01 versus control.
Fig. 3. Syndecan-4 overexpression causes delayed metabolic degradation of PIP2. (A) COS-7 cells were co-transfected with GFP-PHd cDNA and either vector (vec) or syndecan-
4 (sdc4) cDNAs were preincubated with 15 lM LY294002 for 30 min and then incubated in the presence of exogenously added PIP2 (25 lM) for the indicated times. The
percent of cells positive for GFP membrane localization was quantiﬁed. (B) COS-7 cells co-transfected with GFP-PHd cDNA and either vector (vec) or syndecan-4 (sdc4) cDNAs
were preincubated with 10 lMU73122 for 15 min and then incubated in the presence of exogenously added PIP2 (25 lM) for the indicated times. The percent of cells positive
for GFP membrane localization was quantiﬁed. (C) Cells were incubated with 10 lg/ml of ionomycin for the indicated times, and the percent of cells positive for GFP
membrane localization was quantiﬁed. *P < 0.01 versus control.
2398 S. Kwon et al. / FEBS Letters 583 (2009) 2395–2400further enhanced syndecan-4-induced GFP-PHd membrane
targeting, but PLC inhibition did not, the inference drawn is that
syndecan-4 inhibits EGF-mediated metabolic degradation of PIP2
by PLC.4. Discussion
PIP2 is known to bind syndecan-4 with high afﬁnity [24] and to
regulate syndecan-4-mediated focal adhesion and stress ﬁber
Fig. 4. Syndecan-4 inhibits EGF-mediated metabolic degradation of PIP2. (A) COS-7 cells transfected with the indicated cDNAs were treated with 50 ng/ml EGF for the
indicated times. Cells expressing GFP in the plasma membrane were counted. A total of approximately 90 cells were counted for each bar. *P < 0.01 versus control. (B) COS-7
cells were co-transfected with GFP-PHd and either control siRNA (si-con) or siRNA oligonucleotides (si-sdc4) were treated with 50 ng/ml EGF for 30 min. Membrane
localizations of GFP-PHd proteins were examined using ﬂuorescence microscopy (left panel), and cells expressing GFP in the plasma membrane were counted (right panel).
*P < 0.01 versus control. (C) COS-7 cells transfected with the indicated cDNAs were preincubated with 25 lM PIP2 for 30 min and then treated with 50 ng/ml EGF for the
indicated times. Cells expressing GFP in the plasma membrane were counted. (D) Cells were incubated with EGF for the indicated times in the presence of a speciﬁc PI3K
inhibitor (+LY) or a PLC inhibitor (+U73122). Cells expressing GFP in the plasma membrane were counted. A total of approximately 90 cells were counted for each bar.
*P < 0.01 versus control.
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actions of syndecan-4 on PIP2 in this complex have not been ad-
dressed. We report here that syndecan-4 induces an increase in
PIP2 levels in the plasma membrane that reﬂected a delay in PLC-
mediated PIP2 hydrolysis. The implication is that syndecan-4 neg-
atively regulates the metabolic degradation of PIP2, and thereby
maintains a steady-state level and spatial organization of PIP2 in
the plasma membrane. This could be mediated by direct inhibition
of enzymatic activity of PLC by syndecan-4. However, this is less
likely, since PLC activity was not affected by syndecan-4 peptide
in vitro (data not shown). Another possibility is that, syndecan-4
may be involved in sequestration of PIP2 from PLC, like other basic
proteins such as MARCKS [12,14]. Future work will be required to
determine the precise mechanism(s) by which sequestration of
PIP2 by syndecan-4 inhibits PLC-mediated PIP2 degradation. Inter-
estingly, however, our experiments implicate cooperativity be-
tween syndecan-4 and PI3K. Since syndecan-4 expression further
enhanced EGF-mediated PIP2 synthesis (Fig. 4), both syndecan-4
and PI3K seems to act to regulate the cellular level of PIP2. In turn,
PI3K uses PIP2 as its substrate and phosphorylates PIP2 to generate
PIP3, which promotes cell survival, and is the major function of
PI3K. Syndecan-4 is known to positively regulate focal adhesion ki-
nase [26], another key mediator in cell survival, and FAK signaling
to activation of PI3K mediates cell survival. Therefore, syndecan-4
may cooperatively regulate PI3K functions, and PIP2 may be one of
the links between syndecan-4 and PI3K.
Our experiments also implicate that syndecan-4-PIP2 interac-
tions seem to be important in the regulation of both syndecan-4-
and PIP2-mediated cellular processes. This interplay between synd-
ecan-4 and PIP2 might be expected on the basis of the close phys-
ical association of these two molecules and their overlapping
functions in the plasmamembrane. For example, during actin cyto-
skeleton organization, both syndecan-4 and PIP2 are selectively
distributed to lipid raft and/or focal adhesions, where they are in-
volved in inducing actin polymerization [15,27]. The accumulationof PIP2 in these membrane microdomains promotes the recruit-
ment and activation of speciﬁc signaling components, enabling
PIP2 to link the plasma membrane and the actin cytoskeleton
[11,12]. Syndecan-4 is similarly involved in recruiting speciﬁc sig-
naling molecules to the plasma membrane, and also regulates focal
adhesion and actin stress ﬁber formation [15]. During syndecan-4-
mediated actin stress ﬁber formation, actin polymerization is di-
rectly regulated by PIP2 and PIP2-binding proteins; maintaining
adequate steady-state levels of PIP2 at the membrane where synd-
ecan-4-induced actin polymerization occurs is critical to this pro-
cess. The simplest way to maintain this steady-state supply of
PIP2 would be for syndecan-4-PIP2 interactions to directly regulate
the level of PIP2. Our data support such a mechanism, showing that
syndecan-4 directly promotes the retention of PIP2 in the plasma
membrane, and suggesting that syndecan-4 and PIP2 cooperatively
regulate actin cytoskeleton organization. Ongoing efforts in our
laboratory are currently directed at identifying other effector mol-
ecules that may modulate the interplay between syndecan-4 and
PIP2.
Acknowledgements
This research was supported by Basic Science Research Program
through the National Research Foundation of Korea funded by the
Ministry of Education, Science and Technology (2009-0071381 to
ESO) and in part by Grant No. R15-2006-020 from the NCRC pro-
gram of the MEST and the KOSEF through the Center for Cell Sig-
naling and Drug Discovery Research at Ewha Womans University.
References
[1] Berridge, M., Heslop, J.P., Irvine, R.F. and Brown, K.D. (1984) Inositol
trisphosphate and diacylglycerol as second messengers. Biochem. J. 220,
345–360.
[2] Nishizuka, Y. (1988) The molecular heterogeneity of protein kinase C and its
implications for cellular regulation. Nature 34, 661–665.
2400 S. Kwon et al. / FEBS Letters 583 (2009) 2395–2400[3] Czech, M.P. (2000) PIP2 and PIP3: complex roles at the cell surface. Cell 100,
603–606.
[4] Vanhaesebroeck, B. and Waterﬁeld, M.D. (1999) Signaling by distinct classes of
phosphoinositide 3-kinase. Exp. Cell Res. 253, 239–254.
[5] Cantley, L.C. (2002) The phosphoinositide 3-kinase pathway. Science 296,
1655–1657.
[6] Downes, C.P., Gray, A. and Lucocq, J.M. (2005) Probing phosphoinositide
functions in signaling and membrane trafﬁcking. Trends Cell Biol. 15, 259–
268.
[7] Simonsen, A., Wurmser, A.E., Emr, S.D. and Stenmark, H. (2001) The role of
phosphoinositides in membrane transport. Curr. Opin. Cell Biol. 13, 485–492.
[8] Martin, T.F. (2001) Subcellular targeting by membrane lipids. Curr. Opin. Cell
Biol. 13, 146–152.
[9] Yin, H.L. and Janmey, P.A. (2003) Phosphoinositide regulation of the actin
cytoskeleton. Annu. Rev. Physiol. 65, 761–789.
[10] Raucher, D., Stauffer, T., Chen, W., Shen, K., Guo, S., York, J.D., Sheetz, M.P. and
Meyer, T. (2000) Phosphatidylinositol-4,5-bisphosphate functions as a second
messenger that regulates cytoskeleton-plasma membrane adhesion. Cell 100,
221–228.
[11] Gamper, N. and Shapiro, M.S. (2007) Target-speciﬁc PIP2 signalling: howmight
it work. J. Physiol. 582, 967–975.
[12] McLaughlin, S. and Murray, D. (2005) Plasma membrane phosphoinositide
organization by protein electrostatics. Nature 438, 605–611.
[13] McLaughlin, S., Wang, J., Gambhir, A. and Murray, D. (2002) PIP(2) and
proteins: interactions, organization, and information ﬂow. Annu. Rev. Biophys.
Biomol. Struct. 31, 151–175.
[14] Rauch, M.E., Ferguson, C.G., Prestwich, G.D. and Caﬁso, D.S. (2002)
Myristoylated alanine-rich C kinase substrate (MARCKS) sequesters spin-
labeled phosphatidylinositol 4,5-bisphosphate in lipid bilayers. J. Biol. Chem.
277, 14068–14076.
[15] Woods, A. and Couchman, J.R. (2001) Syndecan-4 and focal adhesion function.
Curr. Opin. Cell Biol. 13, 578–583.
[16] Oh, E.S., Woods, A., Lim, S.T. and Couchman, J.R. (1998) Syndecan-4
proteoglycan cytoplasmic domain and phosphatidylinositol-4,5-bisphos-phate coordinately regulate protein kinase C activity. J. Biol. Chem. 273,
10624–10629.
[17] Horowitz, A., Murakami, M., Gao, Y. and Simons, M. (1998)
Phosphatidylinositol 4,5-bisphosphate mediates the interaction of syndecan-
4 with protein kinase C. Biochemistry 38, 15871–15877.
[18] Horowitz, A., Murakami, M., Gao, Y. and Simons, M. (1998) Phosphorylation of
the cytoplasmic tail of syndecan-4 regulates activation of protein kinase
Calpha. J. Biol. Chem. 273, 25548–25551.
[19] Baciu, P.C. and Goetinck, P.F. (1995) Protein kinase C regulates the recruitment
of syndecan-4 into focal contacts. Mol. Biol. Cell 6, 1503–1513.
[20] Keum, E., Kim, Y., Kim, J., Kwon, S., Lim, Y., Han, I. and Oh, E.S. (2004)
Syndecan-4 regulates localization, activity, and stability of protein kinase
Calpha. Biochem. J. 378, 1007–1014.
[21] Medh, J.D. and Weigel, O.H. (1989) Separation of phosphatidylinositols and
other phospholipids by two-step one-dimensional thin-layer
chromatography. J. Lipid Res. 30, 761–764.
[22] Varnai, P., Lin, X., Lee, S.B., Tuymetova, G., Bondeva, T., Spat, A., Rhee, S.G.,
Hajnoczky, G. and Balla, T. (2002) Inositol lipid binding and membrane
localization of isolated pleckstrin homology domains. J. Biol. Chem. 277,
27412–27422.
[23] Harlan, J.E., Hajduk, P.J., Yoon, H.S. and Fesik, S.W. (1994) Pleckstrin homology
domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 371, 168–170.
[24] Couchman, J.R., Vogt, S., Lim, S.T., Lim, Y., Oh, E.S., Prestwich, G.D., Theibert, A.,
Lee, W. and Woods, A. (2002) Regulation of inositol phospholipid binding and
signaling through syndecan-4. J. Biol. Chem. 277, 49296–49303.
[25] Rebecchi, M.J. and Pentyala, S.N. (2000) Structure, function, and control of
phosphoinositide-speciﬁc phospholipase C. Physiological Reviews 80, 1291–
1335.
[26] Wilcox-Adelman, S.A., Denhez, F. and Goetinck, P.F. (2002) Syndecan-4
modulates focal adhesion kinase phosphorylation. J. Biol. Chem. 2004 (277),
32970–32977.
[27] Tkachenko, E. and Simons, M. (2002) Clustering induces redistribution of
syndecan-4 core protein into raft membrane domains. J. Biol. Chem. 277,
19946–19951.
